Self-administration can carry risks such as infection, allergic reactions, improper dosing, pain, bruising, and unexpected side effects
Potency loss may occur without any visible change, meaning the solution could appear intact whilst delivering a sub-therapeutic or unpredictable dose
The TRIUMPH-4 trial also identified dysesthesia (skin sensitivity or tingling) as a new side effect occurring in about 21% of participants at the 12mg dose, though it was generally described as mild
BPC-157 + TB-500 is a research peptide blend discussed in scientific literature involving peptide biology, molecular signaling, protein interactions, extracellular matrix research, and laboratory peptide chemistry
1 Chronic kidney disease in patients with type 2 diabetes is associated with an elevated risk of end-stage kidney disease, cardiovascular disease, and death